Postbiotica | MyStartBCN: a big victory for Postbiotica
POSTBIOTICA is an innovative Biopharmaceutical Company born to develop a new therapeutic treatments based on new molecules with a high biological impact called POSTBIOTICS. We hold a new fermentative process in which we design e modulate the Postbiotics productions.
postbiotica, postbiotics, postbiotics productions, biopharmaceutical company
post-template-default,single,single-post,postid-16612,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-16.7,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.2,vc_responsive

MyStartBCN: a big victory for Postbiotica

MyStartBCN: a big victory for Postbiotica

Postbiotica, represented by Francesca Algieri, won the first edition of the My Start BCN contest and has been rewarded by the President of the Chamber of Commerce, Igor Garzesi. Postbiotica has impressed the jury for the development of new metabolities derivated from bacterial fermentation and used  for the treatment of immune and inflammatory pathologies.

My Start BCN is a program aimed to promote the international growth process of virtuous Italian start-up. My StartBCN is  promoted by the Italian Chamber of Commerce-Barcelona in collaboration with IP3-Polytechnic University of Turin and Talent Garden.

Postbiotica and other 5 Start-up were chosen among the 30 projects presented to access the final phase that was held on October 23 at the Banco Mediolanum in Barcelona. During this phase, each Start-up presented their project to the jury composed by: Abinsula, Aeban, Banco Mediolanum, BarcelonaActiva, Esade Creapolis, Everis, IED, Pymec and Talent Garden.


No Comments

Post A Comment